¿Presenta la enfermedad de Parkinson una haloenzimopatía?
Resumen: Los estudios en el laboratorio han permitido identificar cambios del metabolismo de halógenos en suero y líquido cefalorraquídeo (LCR) de pacientes con enfermedad de Parkinson, que indican la presencia de «autohalogenación acelerada» del LCR de los pacientes o aumento de haloperoxidasas, en...
Main Author: | E. Fernández-Espejo |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier España
2022-10-01
|
Series: | Neurología |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S021348531930026X |
Similar Items
-
Halogenation in Fungi: What Do We Know and What Remains to Be Discovered?
by: Bastien Cochereau, et al.
Published: (2022-05-01) -
The Halogenated Metabolism of Brown Algae (Phaeophyta), Its Biological Importance and Its Environmental Significance
by: Stéphane La Barre, et al.
Published: (2010-03-01) -
Dehalogenases for pollutant degradation in brief: A mini review
by: Sefatullah Zakary, et al.
Published: (2021-02-01) -
Structural Analysis of the Ancestral Haloalkane Dehalogenase AncLinB-DmbA
by: Andrii Mazur, et al.
Published: (2021-11-01) -
Purification and characterization of a novel p,p’-DDT dehalogenase from Aeromonas sp. strain MY1
by: Y. Murtala, et al.
Published: (2021-02-01)